Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,6867,70,89
Msft-1,27
Nokia3,3183,34953,52
IBM0,06
Mercedes-Benz Group AG74,0874,1-0,90
PFE2,40
20.04.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 19.04.2024
Stryker (SYK, NY Consolidated)
Závěr k 19.4.2024 Změna (%) Změna (USD) Objem obchodů (ks)
325,43 -0,62 -2,02 1 884 151
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 20.04.2024
Popis společnosti
Obecné informace
Název společnostiStryker Corp
TickerSYK
Kmenové akcie:Ordinary Shares
RICSYK
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 52 000
Akcie v oběhu k 11.03.2024 380 469 830
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice2825 Airview Blvd
MěstoKALAMAZOO
PSČ49002
ZeměUnited States
Kontatní osobaJason Beach
Funkce kontaktní osobyVice President, Investor Relations
Telefon12 693 892 600
Fax12693851062

Business Summary: Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. The Company operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Stryker's geographical segments include the United States and the International.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Stryker Corp revenues increased 11% to $20.5B. Net income increased 34% to $3.17B. Revenues reflect MedSurg and Neurotechnology segment increase of 12% to $11.84B, Orthopaedics and Spine segment increase of 11% to $8.66B, United States segment increase of 10% to $6.19B, Europe & Middle East & Africa (EMEA) (Region) segment increase of 11% to $2.62B, Other countries segment increase of 17% to $677M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Devices & Implants
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 20.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerKevin Lobo5801.10.202125.04.2011
Chief Financial Officer, Vice PresidentGlenn Boehnlein6201.04.201601.04.2016
Group President - Global Quality and OperationsViju Menon5623.04.201823.04.2018
Group President - MedSurg and NeurotechnologyJ. Andrew Pierce5001.10.202101.10.2021
Group President - Orthopaedics and SpineSpencer Stiles4701.10.202101.10.2021
Chief Human Resource Officer, Vice PresidentM. Kathryn Fink5401.01.2016
Chief Accounting Officer, Vice PresidentWilliam Berry5801.01.2014
Vice President - Chief Corporate Affairs OfficerYin Becker6001.01.2016
Vice President, Chief Legal OfficerRobert Fletcher5322.04.201922.04.2019